Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Canadian Institutes of Health Research (CIHR) | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A health coaching intervention in those with pre-disease (pre-hypertension or pre-diabetes) but without pre-existing cardiovascular disease will effectively help participants change their lifestyle behaviour and prevent or delay onset of cardiovascular disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Health Coaching | Experimental |
| |
| Usual Care -Control | No Intervention | Patients assigned to the control (usual care) group will be advised to seek standard lifestyle counselling from their primary care physician. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Health Coaching | Behavioral | The intervention will take approximately six months to complete. A combination of group and individual face-to-face meetings will be used. Participants will be divided into groups of 20 for group meetings. Groups will be brought together for a group coaching session at the beginning and the end of the coaching process (i.e., intervention). Each participant will also receive four individual coaching sessions with the health coach and will be able to avail of three one-hour telephone coaching sessions during the six month intervention. Participants will be encouraged to utilize telephone coaching for key support periods. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in lifestyle behaviours as measured by the Simple Lifestyle Indicator Questionnaire | baseline, 6 months, 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in Self-efficacy | baseline, 6 months, 12 months | |
| Change from baseline in score on the Framingham-based Global Risk Assessment | baseline, 6 months, 12 months | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marshall Godwin, MD, MSc | Memorial University of Newfoundland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Memorial University of Newfoundland | St. John's | Newfoundland and Labrador | A1B 3V6 | Canada | ||
| Memorial University of Newfoundland |
Not provided
| ID | Term |
|---|---|
| D011236 | Prediabetic State |
| D058246 | Prehypertension |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Change from baseline in blood pressure as measured by the BpTRU device |
| baseline, 6 months, 12 months |
| Change from baseline in fasting blood glucose and HbA1c as measured by the Cholestech Analyser | baseline, 6 months, 12 months |
| Change from baseline in health related quality of life | baseline, 6 months, 12 months |
| St. John's |
| Newfoundland and Labrador |
| A1N 3V6 |
| Canada |
| D004700 | Endocrine System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |